Tomoki Ochiai

Tomoki Ochiai

Interventional cardiologist / Cardiologist
Shonan Kamakura General Hospital - Kamakura-Shi, Japan

Latest contributions

Challenging scenarios in acute coronary syndrome

20 May 2025 – From EuroPCR 2025

This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.

Challenging scenarios in acute coronary syndrome

Expanding indications for TAVI - moderate aortic stenosis and heart failure

09 Feb 2025 – From PCR Tokyo Valves 2025

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

Expanding indications for TAVI - moderate aortic stenosis and heart failure

Mastering TAV-in-SAV: strategies, challenges and advanced techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Want to master the ins and outs of TAV-in-SAV? Don’t miss these presentations!

You’ll get expert guidance on evaluating feasibility, choosing the right transcatheter valve and using advanced techniques (valve fracture, leaflet modification, coronary protection...). Plus, you'll dive into multiple real-world case presentations that tackle challenges, share...

Mastering TAV-in-SAV: strategies, challenges and advanced techniques

Late-Breaking Trial session

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...

Late-Breaking Trial session

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

08 Feb 2025 – From PCR Tokyo Valves 2025

Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

Featured research - Aortic valve (Part 3)

24 Nov 2024 – From PCR London Valves 2024

Featured research - Aortic valve (Part 3)

Percutaneous valvular interventions and cardiogenic shock

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions focused on percutaneous valvular interventions in the context of cardiogenic shock. Learn about complex cases, including severe aortic stenosis with cardiogenic shock, transcatheter treatment of acute heart failure due to surgical prosthetic valve, and acute management of post-AMI papillary...

Percutaneous valvular interventions and cardiogenic shock

TAVI optimisation

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...

TAVI optimisation

Managing aortic stenosis in patients with longer life expectancy

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.

Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...

Facilitating coronary access after TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

TAV-in-TAV and coronary access

17 Feb 2024 – From PCR Tokyo Valves 2024

Learn about the challenges of coronary access during TAV-in-TAV procedure through this series of abstract submissions for PCR Tokyo Valves 2024. Expore the feasibility of redo TAVR in Sapien valves based on in-vivo CT assessment, examine the coaxiality of transcatheter aortic self-expanding valve, and more in...

Selection of the 2024 best abstracts

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...

TAVI for complex valve

19 Feb 2023 – From PCR Tokyo Valves 2023

Join this session to discover TAVI challenges for complex valves. Gain insights into variations in TAVI patient treatment: bicuspid valve with atypical calcium chunk, balloon-expandable valve implantation, sinus sequestration, hybrid therapy and more!

Coronary access after TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

Unlock insights into post-TAVI coronary access. Understand transcatheter aortic valve structure, neo-commissure anatomy, and practical techniques. This session covers topics such as optimising commissure alignment, elective CAG/PCI, ACS, and severe aortic stenosis.

Selection of the 2023 best abstracts

19 Feb 2023 – From PCR Tokyo Valves 2023

Watch this session to discover the best cases and abstracts unveiled at PCR Tokyo Valves 2023, covering topics such as transcatheter aortic valve implantation impact, cerebral protection efficacy, and post-TAVI aortic regurgitation quantification.

Structural heart disease intervention focusing on co-medical roles - Multidisciplinary approach in Japanese style

18 Feb 2023 – From PCR Tokyo Valves 2023

In this session, discover the intricacies of decision-making and a holistic strategy in structural heart disease intervention (in Japenese). Explore interdisciplinary collaboration and evaluate the adequacy of routine work through cases exploring TAVI, MitraClip, and LAAC.

The importance of hemodynamic performance in transcatheter aortic valves

04 Jul 2022

Watch the 1st of #PCRtokyo 2022’s six live webinars about ‘The importance of hemodynamic performance in transcatheter aortic valves’.

Why durability matters: lifetime management considerations for supra-annular TAVR

26 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...

Why durability matters: lifetime management considerations for supra-annular TAVR

Contemporary procedural practice for TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Contemporary procedural practice for TAVI

TAVI and coronary artery disease

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

TAVI and coronary artery disease

PCR Submissions – Discover our inspiring awardees!

05 Jul 2018

View a list of worldwide submitters who have received awards at PCR Courses. Consult their winning presentations and get inspired for the preparation of your own submission. Will YOUR name be added to the list soon?